92
References
1. Aguilar-Salinas CA, Viveros-Ruiz T. Recent advances in managing/understanding the metabolic syndrome. F1000Res. 2019;8:F1000.
2. Fornari E, Maffeis C. Treatment of metabolic syndrome in children. Front Endocrinol.
2019;10:702.
3. Metcalfe LK, Smith GC, Turner N. Defining lipid mediators of insulin resistance: controversies and challenges. J Mol Endocrinol. 2019;62(1):R65–82.
4. Dejman A, Riveros J. Vitamin B1 for type B metabolic acidosis: an underrecognized approach.
Saudi J Kid Dis Transpl. 2018;29(6):1480.
5. Jung B, Martinez M, Claessens Y-E, Darmon M, Klouche K, Lautrette A, et al. Diagnosis and
management of metabolic acidosis: guidelines from a French expert panel. Ann Intensive Care.
2019;9(1):92.
6. Gregory JW. Prevention of obesity and metabolic syndrome in children. Front Endocrinol.
2019;10:669.
7. Gao M, Liu D. Controlling obesity and metabolic diseases by hydrodynamic delivery of a
fusion gene of Exendin-4 and α1 Antitrypsin. Sci Rep. 2019;9(1):1–12.
8. Kim D, Touros A, Kim WR. Nonalcoholic fatty liver disease and metabolic syndrome. Clin
Liver Dis. 2018;22(1):133–40.
9. Khawandanah J. Double or hybrid diabetes: A systematic review on disease prevalence, characteristics and risk factors. Nutr Diabetes. 2019;9(1):1–9.
10. Urbanovych A, Kozlovska K, Urbanovych M. Modern ways of treatment of metabolic disorders in women with polycystic ovarian syndrome. Rom J Diabetes Nutr Metab Dis.
2019;26(3):317–22.
11. Pradas I, Rovira-Llopis S, Naudí A, Bañuls C, Rocha M, Hernandez-Mijares A, et al.
Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic
ovary syndrome women. Sci Rep. 2019;9(1):1–11.
12. Hallett PJ, Engelender S, Isacson O. Lipid and immune abnormalities causing age-dependent
neurodegeneration and Parkinson’s disease. J Neuroinflammation. 2019;16(1):153.
13. Naifeh J, Varacallo M. Biochemistry, aerobic glycolysis. StatPearls [Internet]: StatPearls
Publishing; 2018.
14. Lund J, Aas V, Tingstad RH, Van Hees A, Nikolić N. Utilization of lactic acid in human myotubes and interplay with glucose and fatty acid metabolism. Sci Rep. 2018;8(1):9814.
15. Sun S, Li H, Chen J, Qian Q. Lactic acid: no longer an inert and end-product of glycolysis.
Physiology. 2017;32(6):453–63.
16. Lazzeri C, Valente S, Chiostri M, Gensini GF. Clinical significance of lactate in acute cardiac
patients. World J Cardiol. 2015;7(8):483.
17. Stocker RA. Intensive care in traumatic brain injury including multi-modal monitoring and
neuroprotection. Med Sci. 2019;7(3):37.
18. Liu C, Wu J, Zhu J, Kuei C, Yu J, Shelton J, et al. Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81. J Biol Chem. 2009;284(5):2811–22.
19. Yonejima Y, Ushida K, Mori Y. Effect of lactic acid bacteria on lipid metabolism and fat synthesis in mice fed a high-fat diet. Biosci Microbiota, Food Health. 2013;32(2):51–8.
20. Fruh SM. Obesity: Risk factors, complications, and strategies for sustainable long-term weight
management. J Am Assoc Nurse Pract. 2017;29(S1):S3–S14.
21. Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;1:288–98.
22. Sivamaruthi BS, Kesika P, Suganthy N, Chaiyasut C. A review on role of microbiome in obesity and antiobesity properties of probiotic supplements. BioMed Res Int. 2019;2019:3291367.
23. Broussard J, Brady MJ. The impact of sleep disturbances on adipocyte function and lipid
metabolism. Best Pract Res Clin Endocrinol Metab. 2010;24(5):763–73.
24. Hirotsu C, Tufik S, Andersen ML. Interactions between sleep, stress, and metabolism: From
physiological to pathological conditions. Sleep Sci. 2015;8(3):143–52.
K. Haider et al.
References
1. Aguilar-Salinas CA, Viveros-Ruiz T. Recent advances in managing/understanding the metabolic syndrome. F1000Res. 2019;8:F1000.
2. Fornari E, Maffeis C. Treatment of metabolic syndrome in children. Front Endocrinol.
2019;10:702.
3. Metcalfe LK, Smith GC, Turner N. Defining lipid mediators of insulin resistance: controversies and challenges. J Mol Endocrinol. 2019;62(1):R65–82.
4. Dejman A, Riveros J. Vitamin B1 for type B metabolic acidosis: an underrecognized approach.
Saudi J Kid Dis Transpl. 2018;29(6):1480.
5. Jung B, Martinez M, Claessens Y-E, Darmon M, Klouche K, Lautrette A, et al. Diagnosis and
management of metabolic acidosis: guidelines from a French expert panel. Ann Intensive Care.
2019;9(1):92.
6. Gregory JW. Prevention of obesity and metabolic syndrome in children. Front Endocrinol.
2019;10:669.
7. Gao M, Liu D. Controlling obesity and metabolic diseases by hydrodynamic delivery of a
fusion gene of Exendin-4 and α1 Antitrypsin. Sci Rep. 2019;9(1):1–12.
8. Kim D, Touros A, Kim WR. Nonalcoholic fatty liver disease and metabolic syndrome. Clin
Liver Dis. 2018;22(1):133–40.
9. Khawandanah J. Double or hybrid diabetes: A systematic review on disease prevalence, characteristics and risk factors. Nutr Diabetes. 2019;9(1):1–9.
10. Urbanovych A, Kozlovska K, Urbanovych M. Modern ways of treatment of metabolic disorders in women with polycystic ovarian syndrome. Rom J Diabetes Nutr Metab Dis.
2019;26(3):317–22.
11. Pradas I, Rovira-Llopis S, Naudí A, Bañuls C, Rocha M, Hernandez-Mijares A, et al.
Metformin induces lipid changes on sphingolipid species and oxidized lipids in polycystic
ovary syndrome women. Sci Rep. 2019;9(1):1–11.
12. Hallett PJ, Engelender S, Isacson O. Lipid and immune abnormalities causing age-dependent
neurodegeneration and Parkinson’s disease. J Neuroinflammation. 2019;16(1):153.
13. Naifeh J, Varacallo M. Biochemistry, aerobic glycolysis. StatPearls [Internet]: StatPearls
Publishing; 2018.
14. Lund J, Aas V, Tingstad RH, Van Hees A, Nikolić N. Utilization of lactic acid in human myotubes and interplay with glucose and fatty acid metabolism. Sci Rep. 2018;8(1):9814.
15. Sun S, Li H, Chen J, Qian Q. Lactic acid: no longer an inert and end-product of glycolysis.
Physiology. 2017;32(6):453–63.
16. Lazzeri C, Valente S, Chiostri M, Gensini GF. Clinical significance of lactate in acute cardiac
patients. World J Cardiol. 2015;7(8):483.
17. Stocker RA. Intensive care in traumatic brain injury including multi-modal monitoring and
neuroprotection. Med Sci. 2019;7(3):37.
18. Liu C, Wu J, Zhu J, Kuei C, Yu J, Shelton J, et al. Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81. J Biol Chem. 2009;284(5):2811–22.
19. Yonejima Y, Ushida K, Mori Y. Effect of lactic acid bacteria on lipid metabolism and fat synthesis in mice fed a high-fat diet. Biosci Microbiota, Food Health. 2013;32(2):51–8.
20. Fruh SM. Obesity: Risk factors, complications, and strategies for sustainable long-term weight
management. J Am Assoc Nurse Pract. 2017;29(S1):S3–S14.
21. Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;1:288–98.
22. Sivamaruthi BS, Kesika P, Suganthy N, Chaiyasut C. A review on role of microbiome in obesity and antiobesity properties of probiotic supplements. BioMed Res Int. 2019;2019:3291367.
23. Broussard J, Brady MJ. The impact of sleep disturbances on adipocyte function and lipid
metabolism. Best Pract Res Clin Endocrinol Metab. 2010;24(5):763–73.
24. Hirotsu C, Tufik S, Andersen ML. Interactions between sleep, stress, and metabolism: From
physiological to pathological conditions. Sleep Sci. 2015;8(3):143–52.
K. Haider et al.